Vytorin Scripts Plummet In the wake of the ENHANCE study, new prescriptions of the cholesterol-lowering drug Vytorin are dropping drastically, but calls to sales reps by physicians are on the rise. Click to read full story>>>
Vermont Amends Data Mining Law After watching similar legislation barring data mining for Rx info get shut down in Maine and New Hampshire, Vermont changes tactics and amends its law. Click to read full story>>>
Hold That Call: Physician Detailing Preferences Revealed Doctors have always considered detailing a necessary evil, but a new survey breaks down just how hard (or easy) it is for sales reps to get face time with physicians. Click to read full story>>>
Your email is never published nor shared. Required fields are marked *
You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
PharmExec Blog
Follow Us
RSS
Bookstore
Pharm Exec News Analysis : February 1, 2008
In the wake of the ENHANCE study, new prescriptions of the cholesterol-lowering drug Vytorin are dropping drastically, but calls to sales reps by physicians are on the rise.
Click to read full story>>>
Vermont Amends Data Mining Law
After watching similar legislation barring data mining for Rx info get shut down in Maine and New Hampshire, Vermont changes tactics and amends its law.
Click to read full story>>>
Hold That Call: Physician Detailing Preferences Revealed
Doctors have always considered detailing a necessary evil, but a new survey breaks down just how hard (or easy) it is for sales reps to get face time with physicians.
Click to read full story>>>